Faculty

Institution

Unit

Venue

Brian Boulmay

Louisiana State University Health Sciences Center, New Orleans

Affiliations

Division Of Research

School of Medicine

Division of Hematology & Oncology

NoneBrian Boulmay is currently serving as a Division Of Research faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Brian Boulmay

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

oncology pathology medicine radiation oncology cancer care cancer treatment pharmacology cancer research cancer immunotherapy lung cancer immunotherapy hepatology thoracic oncology medicinal research new orleans cancer cells surgical pathology anti-cancer agents liver cancer cellular therapy surgical oncology cancer management colorectal cancer neuro-oncology pharmacotherapy brain tumor research experimental medicine radiation therapy neck oncology therapeutic vaccines hepatocellular carcinoma neck cancer case report gliomas jama oncology medical virology medical systems health systems disaster medicine therapeutic efficacy multiple pulmonary nodule pancreatic cancer clinical radiation oncology malignant disease vaccine trials 56-year-old man hurricane katrina medical oncology services emergency nursing clinical immunology pancreatic fluid collection thyroid disease hepatobiliary tumors cell therapy professional preparation student success immunomodulation tumor targeting biomarker target heme homeostasis laboratory hematology viral persistence brain lesion early diagnosis field trial clinical neurology overall survival durable tumor regression first-line therapy first-line pembrolizumab salvage therapies three-year survival abdominal pain psa flare central role multidisciplinary approach

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase 1B/2 Study on the Efficacy and Safety of Bxq-350, a First-In-Class Sphingolipid Metabolism Modulator, in Combination With Mfolfox7 and Bevacizumab in Newly Diagnosed Metastatic Colorectal Carcinoma.. Journal of Clinical Oncology (2026)

pharmacologypathologymolecular cancercancer treatmentmetastatic colorectal carcinomaoncogenescolorectal canceroncologyphase 1b/2cancer discoverymetastasisanti-cancer agentsmedicinal researchcancer cells

Bxq-350 Efficacy and Safety Evaluation in First Line Mcrc Patients: A Phase 1B/2 Study of Bxq-350, a First-In-Class Sphingolipid Metabolism Modulator, in Combination With Mfolfox7 Plus Bevacizumab in Newly Diagnosed Metastatic Colorectal Carcinoma.. Journal of Clinical Oncology (2026)

safety evaluationpharmacologypathologymolecular cancercancer treatmentcolorectal canceroncologyphase 1b/2cancer discoveryradiation oncologymetastasismedicinal researchcancer cellsbxq-350 efficacy

Bxq-350 in Combination With Folfox7 and Bevacizumab: Evaluation of Effect on Oxaliplatin-Induced Cipn—a Phase 1B/2 Trial to Assess the Efficacy and Safety of Bxq-350, a First-In-Class Sphingolipid Metabolism Modulator, in Newly Diagnosed Metastatic Colorectal Carcinoma.. Journal of Clinical Oncology (2026)

pharmacologymolecular cancercancer treatmentmetastatic colorectal carcinomaoncogenescolorectal canceroncologycancer discoveryradiation oncologymetastasisanti-cancer agentsmedicinal researchcancer cellstherapeutic targets

Abstract P1-10-19: Hypophysitis and Haziness in Her2: A Case of Breast Cancer With Leptomeningeal Carcinomatosis. Clinical Cancer Research (2025)

pathologybreast cancerabstract p1-10-19gynecologyleptomeningeal carcinomatosis

Comparative Analysis of Health Disparities in Prostate Cancer Patients With and Without Venous Thromboembolism, and With and Without Anticoagulation Therapy.. Journal of Clinical Oncology (2025)

urologyanticoagulation therapymedicineoncologythrombosishealth disparitiesanticoagulantsvenous thrombosishematologycancer carecomparative analysisprostate cancer

Current Trends in Clinical Trials for Merkel Cell Carcinoma (MCC). Cancers (2025)

pathologycancer treatmentcancer researchoncologymalignant diseasesurgical oncologydermatologycancer caremerkel cell carcinoma

Epidemiological Characteristics Affecting Cholangiocarcinoma Patients With and Without Hepatitis B C: A Retrospective Analysis.. Journal of Clinical Oncology (2025)

hepatologypathologyhepatitis bhepatitisretrospective analysisliver transplantationliver canceroncologyclinical epidemiologycholangiocarcinoma patientsbiliary cancerepidemiology

Bxq-350: A Phase 1B/2 Placebo Controlled, Double Blinded Study on the Efficacy and Safety of Bxq-350 in Combination With Mfolfox7 and Bevacizumab in Newly Diagnosed Metastatic Colorectal Carcinoma (Mcrc).. Journal of Clinical Oncology (2024)

Reema Anil PatelAri David BaronBrian C. BoulmayDaniel Blake FloraJulie Anne L GemmillFa Chyi LeeDavendra SohalGrant Richard WilliamsRichard Charles CurryMichael GazdaJoseph D. PurvisGilles TapolskyRay Takigiku

hepatologypharmacologycancer immunotherapytumor targetinghealth sciencesmetastatic colorectal carcinomacancer researchcolorectal canceroncologyradiation oncologytherapeutic efficacyanti-cancer agentsclinical researchmedicinal researchbiomarker targetcancer care

Ltbk-02. Evaluation of Paxalisib in Gbm Agile Phase 3 Registration Platform Trial for Newly Diagnosed and Recurrent Glioblastoma. Neuro-Oncology (2024)

Ingo K MellinghoffTimothy CloughesyBrian AlexanderDonald A BerryMeredith BuxtonWebster CaveneeHoward ColmanJohn de GrootBenjamin M EllingsonGary B GordonAndrew B LassmanMichael LimMustafa KhasrawJames PerryErik P SulmanMichael WellerPatrick WenW K Alfred YungNicholas BerryTodd GravesMichelle DetryE M Viktoria HyddmarkAdam JohnssonHeather KlingAnna McGlothlinAshley PowellSarah UntchElisa AquilantiNicholas BlondinBrian BoulmayMacarena de la FuenteJan DrappatzJustin JordanThomas J KaleyMina LobbousTom MikkelsenHerbert NewtonScott OwenKatherine PetersDavid SchiffWendy ShermanShiao-Pei WeathersMichael YoussefJohn FriendEudocia Lee

neurosurgerybrain lesionearly diagnosisneuroscienceneuro-oncologygliomasvascular biologymolecular diagnosticsneurologyfield trialoncologyregistration platform trialbrain tumor researchcancer managementclinical trialsurologyneuroimagingrecurrent glioblastomamedicinal researchclinical neurology

Ret Mutated Non-Small Cell Lung Cancer (Nsclc) in Association With Patients From Central America. Respiratory Medicine Case Reports (2024)

pathologyadvanced lung diseasecentral americamedicineoncogenesoncologyradiation oncologycancer geneticsthoracic oncologylung cancer

1
2
3
4
5
6
10 / page

Brian Boulmay

Louisiana State University Health Sciences Center, New Orleans

Affiliations

Division Of Research

School of Medicine

Division of Hematology & Oncology

NoneBrian Boulmay is currently serving as a Division Of Research faculty at Louisiana State University Health Sciences Center, New Orleans.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Brian Boulmay

Louisiana State University Health Sciences Center, New Orleans

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

safety evaluationpharmacologypathologymolecular cancercancer treatmentcolorectal canceroncologyphase 1b/2cancer discoveryradiation oncologymetastasismedicinal researchcancer cellsbxq-350 efficacy

Abstract P1-10-19: Hypophysitis and Haziness in Her2: A Case of Breast Cancer With Leptomeningeal Carcinomatosis. Clinical Cancer Research (2025)

pathologybreast cancerabstract p1-10-19gynecologyleptomeningeal carcinomatosis

Comparative Analysis of Health Disparities in Prostate Cancer Patients With and Without Venous Thromboembolism, and With and Without Anticoagulation Therapy.. Journal of Clinical Oncology (2025)

urologyanticoagulation therapymedicineoncologythrombosishealth disparitiesanticoagulantsvenous thrombosishematologycancer carecomparative analysisprostate cancer

Current Trends in Clinical Trials for Merkel Cell Carcinoma (MCC). Cancers (2025)

pathologycancer treatmentcancer researchoncologymalignant diseasesurgical oncologydermatologycancer caremerkel cell carcinoma

Epidemiological Characteristics Affecting Cholangiocarcinoma Patients With and Without Hepatitis B C: A Retrospective Analysis.. Journal of Clinical Oncology (2025)

hepatologypathologyhepatitis bhepatitisretrospective analysisliver transplantationliver canceroncologyclinical epidemiologycholangiocarcinoma patientsbiliary cancerepidemiology

Ltbk-02. Evaluation of Paxalisib in Gbm Agile Phase 3 Registration Platform Trial for Newly Diagnosed and Recurrent Glioblastoma. Neuro-Oncology (2024)

Ret Mutated Non-Small Cell Lung Cancer (Nsclc) in Association With Patients From Central America. Respiratory Medicine Case Reports (2024)

pathologyadvanced lung diseasecentral americamedicineoncogenesoncologyradiation oncologycancer geneticsthoracic oncologylung cancer

1
2
3
4
5
6
10 / page